Palo Alto Investors LP - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 187 filers reported holding PROTHENA CORP PLC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q3 2023$79,972,349
-29.3%
1,657,4580.0%7.57%
-17.2%
Q2 2023$113,171,232
+40.3%
1,657,458
-0.4%
9.14%
+36.9%
Q1 2023$80,643,271
-19.3%
1,663,777
+0.3%
6.68%
-21.6%
Q4 2022$99,929,264
-0.1%
1,658,577
+0.5%
8.52%
+7.7%
Q3 2022$100,026,000
+119.1%
1,649,777
-1.9%
7.91%
+98.8%
Q2 2022$45,652,000
-25.8%
1,681,4770.0%3.98%
-16.3%
Q1 2022$61,492,000
-26.1%
1,681,477
-0.2%
4.75%
-10.6%
Q4 2021$83,253,000
-30.6%
1,685,2820.0%5.32%
-26.6%
Q3 2021$120,043,000
+34.9%
1,685,282
-2.7%
7.24%
+47.7%
Q2 2021$89,015,000
+103.4%
1,731,482
-0.6%
4.90%
+96.7%
Q1 2021$43,772,000
+115.4%
1,742,505
+3.0%
2.49%
+134.2%
Q4 2020$20,319,000
+53.1%
1,691,805
+27.3%
1.06%
+46.1%
Q3 2020$13,274,000
+64.6%
1,328,734
+72.3%
0.73%
+50.6%
Q2 2020$8,065,000
-2.8%
771,065
-0.5%
0.48%
-30.4%
Q1 2020$8,296,000
-47.2%
775,296
-21.9%
0.70%
-19.7%
Q4 2019$15,715,000
+99.6%
992,749
-1.2%
0.86%
+64.8%
Q3 2019$7,875,000
-32.8%
1,004,449
-9.4%
0.52%
-7.9%
Q2 2019$11,717,000
-12.9%
1,108,5100.0%0.57%
+1.6%
Q1 2019$13,446,000
+17.8%
1,108,5100.0%0.56%
-7.7%
Q4 2018$11,418,000
-20.9%
1,108,510
+0.5%
0.61%
+4.3%
Q3 2018$14,431,000
-10.3%
1,103,3250.0%0.58%
-9.3%
Q2 2018$16,086,000
-60.2%
1,103,325
+0.2%
0.64%
-62.8%
Q1 2018$40,430,000
-1.6%
1,101,338
+0.5%
1.73%
-2.3%
Q4 2017$41,076,000
-42.1%
1,095,6550.0%1.77%
-40.8%
Q3 2017$70,966,000
+22.1%
1,095,655
+2.0%
2.99%
+10.2%
Q2 2017$58,122,000
-1.3%
1,073,955
+1.7%
2.71%
-2.6%
Q1 2017$58,906,000
+20.5%
1,055,855
+6.2%
2.78%
-0.2%
Q4 2016$48,888,000
-12.8%
993,855
+6.4%
2.79%
-14.3%
Q3 2016$56,039,000
+103.3%
934,455
+18.5%
3.26%
+56.3%
Q2 2016$27,570,000
-3.7%
788,618
+13.4%
2.08%
-6.3%
Q1 2016$28,628,000
-39.6%
695,5180.0%2.22%
-15.7%
Q4 2015$47,372,000
+50.1%
695,518
-0.1%
2.64%
+73.8%
Q3 2015$31,553,000
-13.9%
695,9180.0%1.52%
-6.9%
Q2 2015$36,654,000
+38.1%
695,9180.0%1.63%
+24.2%
Q1 2015$26,542,000
+85.0%
695,918
+0.7%
1.31%
+55.8%
Q4 2014$14,350,000
-3.9%
691,218
+2.6%
0.84%
-24.6%
Q3 2014$14,932,000
+24.0%
673,818
+26.2%
1.12%
+24.4%
Q2 2014$12,042,000
-70.5%
534,018
-49.9%
0.90%
-46.9%
Q1 2014$40,832,000
+186.5%
1,065,836
+98.3%
1.69%
+27.0%
Q4 2013$14,252,000
+696.2%
537,418
+507.3%
1.33%
+606.9%
Q3 2013$1,790,000
+56.6%
88,5000.0%0.19%
+39.3%
Q2 2013$1,143,00088,5000.14%
Other shareholders
PROTHENA CORP PLC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 11,584,280$558,941,51018.85%
Finepoint Capital LP 349,300$16,853,7258.39%
Palo Alto Investors LP 1,657,458$79,972,3497.57%
Birchview Capital, LP 169,574$8,181,9466.96%
First Light Asset Management, LLC 1,494,039$72,087,3826.85%
DCF Advisers, LLC 82,950$4,002,3382.18%
Prosight Management, LP 126,202$6,089,2471.93%
PFM Health Sciences, LP 836,571$40,364,5511.90%
SECTORAL ASSET MANAGEMENT INC 172,407$8,318,6381.62%
Boxer Capital, LLC 625,000$30,156,2501.60%
View complete list of PROTHENA CORP PLC shareholders